Back
Avista Corp. 10K Form
Buy
57
AVA
Avista Corp.
Last Price:
$41.34
Seasonality Move:
1.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | AVA/Avista Corp. Quarterly |
| 2024-02-21 | 10K | AVA/Avista Corp. Annual |
| 2023-11-01 | 10Q | AVA/Avista Corp. Quarterly |
| 2023-08-02 | 10Q | AVA/Avista Corp. Quarterly |
| 2023-05-03 | 10Q | AVA/Avista Corp. Quarterly |
| 2023-02-22 | 10K | AVA/Avista Corp. Annual |
Receive AVA News And Ratings
See the #1 stock for the next 7 days that we like better than AVA
AVA Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $-116M |
| Price / Cash Flow: | 264.51 |
| Annual Sales: | $32.96 |
| Price / Book: | 1.28 |
Profitability
| EPS (TTM): | 2.38490 |
|---|---|
| Net Income (TTM): | $193M |
| Gross Margin: | $475M |
| Return on Equity: | 7.29% |
| Return on Assets: | 2.35% |
Avista Corp. Earnings Forecast
Key Avista Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for AVA is 24.19%.
-
The Selling, General & Administrative Expenses for AVA have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 76.68% of Operating Income.
-
The Net Earning history of AVA is 9.83% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 21 years.
Avista Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Multi-Utilities |
| Sector: | Utilities |
| Current Symbol: | AVA |
| CUSIP: | 05379B |
| Website: | investor.avistacorp.com |
Debt
| Debt-to-Equity Ratio: | 1.22 |
|---|---|
| Current Ratio: | 0.83 |
| Quick Ratio: | 0.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.64 |
|---|---|
| Forward P/E Ratio: | 14.85 |
AVA Technical Analysis vs Fundamental Analysis
Buy
57
Avista Corp. (AVA)
is a Buy
Is Avista Corp. a Buy or a Sell?
-
Avista Corp. stock is rated a BuyThe current Avista Corp. [AVA] share price is $41.34. The Score for AVA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.